ROCHESTER, N.Y., Oct. 14, 2015 /PRNewswire/ -- VirtualScopics,
Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging
solutions, today announced it will report its third quarter 2015
financial results at the 4:00 p.m. ET
market close on Thursday, October 29,
2015. Eric T. Converse,
president and chief executive officer, and Jim Groff, chief financial officer, will host a
conference call and webcast to discuss the company's financial
results and provide a business update at 4:30 p.m. ET that afternoon. The conference
call and webcast information are as follows:
Domestic Call Dial In: 877-407-8035
International Call Dial In: 201-689-8035
Conference Call ID: 13622413
An accompanying slide presentation to enhance managements' formal
remarks, as well as a webcast of the call, can be accessed at the
following links:
http://virtualscopics.investorroom.com/webcasts
or
http://www.investorcalendar.com/IC/CEPage.asp?ID=174428.
A replay and slide presentation will be available one hour after
the conclusion of the conference call for 90 days, and can be
accessed accordingly:
Replay Domestic Dial In: 877-660-6853
Replay International Dial In: 201-612-7415
Replay Conference Call ID: 13622413
The webcast and slide presentation can be accessed at the following
links:
http://virtualscopics.investorroom.com/webcasts
or
http://www.investorcalendar.com/IC/CEPage.asp?ID=174428.
About VirtualScopics, Inc.
VirtualScopics, Inc.
(NASDAQ:VSCP) is a leading provider of clinical trial imaging
solutions to accelerate drug and medical device development.
For risk-averse, time-constrained Clinical Trial Study Teams,
Medical Directors and Imaging Scientists who require quality
imaging data delivered on-time, within budget and on a consistent
basis, VirtualScopics' clinical trial imaging solutions are an
inspired true exception to commonly accepted services provided by
other clinical trial imaging providers. Because of the
scientific and operational flexibility and responsiveness
available, VirtualScopics' clinical trial imaging solutions deliver
special performance advantages compared to other image service
providers that offer common, every day clinical trial imaging
services. For more information about VirtualScopics, Inc.,
please visit www.virtualscopics.com.
Forward-looking Statements
The statements contained in
this press release that are not purely historical are
forward-looking statements within the meaning of the Section 27A of
the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended, and are intended to be
covered by the safe harbors created thereby. These
forward-looking statements include, but are not limited to,
statements regarding the expected benefits of the Company's
investment in infrastructure, sales and marketing efforts, the
increase in backlog, awards and bookings and the performance of
existing projects and/or statements preceded by, followed by or
that include the words "believes", "could", "expects",
"anticipates", "estimates", "intends", "plans", "projects",
"seeks", or similar expressions. Forward-looking statements
deal with the company's current plans, intentions, beliefs and
expectations. Investors are cautioned that all
forward-looking statements involve risks and uncertainties that
could cause actual results to differ materially from those in the
forward-looking statements. Many of these risks and
uncertainties are discussed in the company's Annual Report on Form
10-K for the fiscal year ended December 31,
2014 filed with the Securities and Exchange Commission (the
"SEC"), and in any subsequent reports filed with the SEC,
all of which are available at the SEC's website at
www.sec.gov. These include without limitation: the risk of
cancellation or delay of customer contracts or that contract awards
do not turn into signed contracts. Other risks include the
company's dependence on its largest customers and risk of contract
performance, protection of our intellectual property and the risks
of infringement on the intellectual property rights of
others. All forward-looking statements speak only as of the
date of this press release and the company undertakes no obligation
to update such forward-looking statements.
For More Information, Contact:
Donna N. Stein, APR, Fellow PRSA
Managing Partner
Donna Stein & Partners
315-361-4672
Email: dstein1@twcny.rr.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/virtualscopics-inc-schedules-third-quarter-2015-financial-results-press-release-conference-call-and-webcast-300158782.html
SOURCE VirtualScopics, Inc.